Rating History for Diffusion Pharma (DFFN) by H.C. Wainwright

More Stocks Rated by H.C. Wainwright | Latest Ratings for DFFN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/16/2022 Swayampakula Ramakanth Upgrade Buy
(Neutral)		 9.50
(N/A)		 7.00
(4.40)		 -37.14% Details